Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Divergent trajectories of antiviral memory after SARS-CoV-2 infection

Journal article

Tomic A. et al, (2022), Nature Communications, 13

An introduction to the Marburg virus vaccine consortium, MARVAC.

Journal article

Cross RW. et al, (2022), PLoS pathogens, 18

A prototype lateral flow assay for detection of orthopoxviruses.

Journal article

Ulaeto DO. et al, (2022), The Lancet. Infectious diseases, 22, 1279 - 1280

SARS-CoV-2-Specific T Cell Responses Are Not Associated with Protection against Reinfection in Hemodialysis Patients

Journal article

Shankar S. et al, (2022), Journal of the American Society of Nephrology, 33, 883 - 887

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV

Journal article

Ogbe A. et al, (2022), JCI Insight, 7

Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing

Journal article

Salam AP. et al, (2022), PLOS Neglected Tropical Diseases, 16, e0010289 - e0010289

Multisystem screening reveals SARS-CoV-2 in neurons of the myenteric plexus and in megakaryocytes.

Journal article

Gray-Rodriguez S. et al, (2022), The Journal of pathology

Development of anti-Crimean-Congo hemorrhagic fever virus Gc and NP-specific ELISA for detection of antibodies in domestic animal sera.

Journal article

Belij-Rammerstorfer S. et al, (2022), Frontiers in veterinary science, 9

Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses.

Journal article

Gartlan C. et al, (2022), Frontiers in immunology, 13

ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models

Journal article

Lambe T. et al, (2021), Communications Biology, 4

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

Journal article

Payne RP. et al, (2021), Cell, 184, 5699 - 5714.e11

Filovirus Neutralising Antibodies: Mechanisms of Action and Therapeutic Application.

Journal article

Hargreaves A. et al, (2021), Pathogens (Basel, Switzerland), 10

Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks.

Journal article

Keita AK. et al, (2021), Nature, 597, 539 - 543

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

Journal article

Liu C. et al, (2021), Cell, 184, 4220 - 4236.e13

Metagenomic identification of a new sarbecovirus from horseshoe bats in Europe.

Journal article

Crook JM. et al, (2021), Scientific reports, 11

Antibody evasion by the P.1 strain of SARS-CoV-2

Journal article

Dejnirattisai W. et al, (2021), Cell, 184, 2939 - 2954.e9

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

Journal article

Zhou D. et al, (2021), Cell, 184, 2348 - 2361.e6

Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study

Journal article

Thom R. et al, (2021), The Lancet Infectious Diseases, 21, 507 - 516

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

Journal article

Supasa P. et al, (2021), Cell, 184, 2201 - 2211.e7

The antigenic anatomy of SARS-CoV-2 receptor binding domain

Journal article

Dejnirattisai W. et al, (2021), Cell, 184, 2183 - 2200.e22

Load More